<DOC>
	<DOC>NCT02632175</DOC>
	<brief_summary>This study assesses the long-term safety and efficacy of adalimumab in pediatric subjects with ulcerative colitis.</brief_summary>
	<brief_title>Long-term Safety and Efficacy Study of Adalimumab in Pediatric Subjects With Ulcerative Colitis</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis, Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<criteria>Subject must have successfully enrolled and completed M11290 study Subject considered by the investigator, for any reason, to be an unsuitable candidate</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Ulcerative Colitis</keyword>
</DOC>